These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 27543219)

  • 1. Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset.
    Denny G; Anadkat MJ
    J Am Acad Dermatol; 2016 Sep; 75(3):632-634. PubMed ID: 27543219
    [No Abstract]   [Full Text] [Related]  

  • 2. Hidradenitis Suppurativa Associated with Down Syndrome Is Characterized by Early Age at Diagnosis.
    Giovanardi G; Chiricozzi A; Bianchi L; De Simone C; Dini V; Franceschini C; Garcovich S; Oranges T; Di Raimondo C; Caposiena Caro DR; Romanelli M; Peris K
    Dermatology; 2018; 234(1-2):66-70. PubMed ID: 29689550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
    Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
    J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.
    Garg A; Birabaharan M; Strunk A
    J Am Acad Dermatol; 2018 Jul; 79(1):71-76. PubMed ID: 29339240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hidradenitis suppurativa: Epidemiology and scope of the problem.
    Jemec GB; Kimball AB
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S4-7. PubMed ID: 26470614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenitis suppurativa in the pediatric population.
    Liy-Wong C; Pope E; Lara-Corrales I
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hidradenitis suppurativa among patients with Down syndrome: a population-based cross-sectional analysis.
    Garg A; Strunk A; Midura M; Papagermanos V; Pomerantz H
    Br J Dermatol; 2018 Mar; 178(3):697-703. PubMed ID: 28662304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of clinical spondyloarthritis features in patients with hidradenitis suppurativa.
    Rondags A; van Straalen KR; Arends S; van der Zee HH; Prens EP; Spoorenberg A; Horváth B
    J Am Acad Dermatol; 2019 Feb; 80(2):551-554.e1. PubMed ID: 30554892
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence and Description of Hidradenitis Suppurativa in Down Syndrome: A Cross-sectional Study of 783 Subjects.
    Poizeau F; Sbidian E; Mircher C; Rebillat AS; Chosidow O; Wolkenstein P; Ravel A; Hotz C
    Acta Derm Venereol; 2019 Mar; 99(3):351-352. PubMed ID: 30460373
    [No Abstract]   [Full Text] [Related]  

  • 10. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study.
    Deckers IE; Janse IC; van der Zee HH; Nijsten T; Boer J; Horváth B; Prens EP
    J Am Acad Dermatol; 2016 Oct; 75(4):755-759.e1. PubMed ID: 27453539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Color Doppler ultrasound assessment of morphology and types of fistulous tracts in hidradenitis suppurativa (HS).
    Wortsman X; Castro A; Figueroa A
    J Am Acad Dermatol; 2016 Oct; 75(4):760-767. PubMed ID: 27498279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic associations of hidradenitis suppurativa.
    Kohorst JJ; Kimball AB; Davis MD
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S27-35. PubMed ID: 26470611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hidradenitis suppurativa in Brazil: a population survey.
    Ianhez M; Schmitt JV; Miot HA
    Int J Dermatol; 2018 May; 57(5):618-620. PubMed ID: 29517130
    [No Abstract]   [Full Text] [Related]  

  • 14. Hidradenitis suppurativa and Down syndrome in a single-centre sample: A cross-sectional study.
    Hernández-Rodríguez JC; Osorio-Gómez GF; Ortiz-Álvarez J; Lebrón-Martín JA; Conejo-Mir J; Pereyra-Rodríguez JJ
    Australas J Dermatol; 2022 Aug; 63(3):e231-e237. PubMed ID: 35567765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa.
    Dessinioti C; Tzanetakou V; Zisimou C; Kontochristopoulos G; Antoniou C
    Int J Dermatol; 2018 Jun; 57(6):687-691. PubMed ID: 29604044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Hidradenitis Suppurativa and Lymphoma.
    Tannenbaum R; Strunk A; Garg A
    JAMA Dermatol; 2019 May; 155(5):624-625. PubMed ID: 30698627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidradenitis suppurativa and associated factors: still unsolved problems.
    Matusiak L; Bieniek A; Szepietowski JC
    J Am Acad Dermatol; 2009 Aug; 61(2):362-5. PubMed ID: 19615551
    [No Abstract]   [Full Text] [Related]  

  • 18. Demographic and clinical features of hidradenitis suppurativa in Korea.
    Yang JH; Moon J; Kye YC; Kim KJ; Kim MN; Ro YS; Park MY; Ahn HH; Lee MW; Lee WJ; Lee JH; Lee JB; Jang MS; Choi YS; Choi YW; Suh DH;
    J Dermatol; 2018 Dec; 45(12):1389-1395. PubMed ID: 30294846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis suppurativa in children: The Henry Ford experience.
    Braunberger TL; Nicholson CL; Gold L; Nahhas AF; Jacobsen G; Parks-Miller A; Hamzavi IH
    Pediatr Dermatol; 2018 May; 35(3):370-373. PubMed ID: 29575194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adolescent-Onset Hidradenitis Suppurativa: Prevalence, Risk Factors and Disease Features.
    Molina-Leyva A; Cuenca-Barrales C
    Dermatology; 2019; 235(1):45-50. PubMed ID: 30368494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.